Glenmede Trust’s Insmed INSM Stock Holding History

Glenmede Trust’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,916	Closed	-$313K	–	1532
2026 Q1	$313K	Buy	1,916 +98	+5%	+$15.1K	﹤0.01%	1138
2025 Q4	$316K	Buy	+1,818	New	+$332K	﹤0.01%	1117
2025 Q1	$881K	Buy	11,550 +6,799	+143%	+$520K	﹤0.01%	740
2024 Q4	$328K	Buy	+4,751	New	+$342K	﹤0.01%	1064
2020 Q4	–	Sell	-862	Closed	-$27K	–	1714
2020 Q3	$27K	Buy	862 +35	+4%	+$1.01K	﹤0.01%	1498
2020 Q2	$22K	Sell	827 -739	-47%	-$17.5K	﹤0.01%	1550
2020 Q1	$37K	Hold	1,566	–	–	﹤0.01%	1809
2019 Q4	$37K	Hold	1,566	–	–	﹤0.01%	1809
2019 Q3	$27K	Hold	1,566	–	–	﹤0.01%	1906
2019 Q2	$40K	Hold	1,566	–	–	﹤0.01%	1789
2019 Q1	$45K	Hold	1,566	–	–	﹤0.01%	1731
2018 Q4	$20K	Buy	+1,566	New	+$25K	﹤0.01%	1986

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Glenmede Trust's INSM Position: Q2 2026 in Review

Glenmede Trust sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,916 shares — an estimated $313K sold.

Glenmede Trust first reported a position in INSM in Q4 2018 and held it in 12 quarters. The position peaked at $881K in Q1 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Glenmede Trust reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Glenmede Trust sold 1,916 Insmed shares in Q2 2026, an estimated $313K.
Glenmede Trust first reported a position in Insmed in Q4 2018 and held it in 12 quarters.
Glenmede Trust's Insmed position peaked at $881K in Q1 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.